Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)

Clinical trial NCT02856867 · WITHDRAWN

Trial details

NCT number: NCT02856867
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophagogastric Adenocarcinoma Metastatic Disease No Previous Chemotherapy for Metastatic Esophagogastric Cancer

Start date: 2016-12-01
Primary completion: 2019-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.